Generic placeholder image

Current Drug Metabolism

Editor-in-Chief

ISSN (Print): 1389-2002
ISSN (Online): 1875-5453

Review Article

Recent Advances in Biotransformation by Cunninghamella Species

Author(s): Manoela Daiele Gonçalves*, Fernanda Tomiotto-Pellissier, Ricardo Luís Nascimento de Matos, João Paulo Assolini, Bruna Taciane da Silva Bortoleti, Virginia Marcia Concato, Taylon Felipe Silva, Janice Aparecida Rafael, Wander Rogério Pavanelli, Ivete Conchon-Costa and Nilton Syogo Arakawa

Volume 22, Issue 13, 2021

Published on: 13 December, 2021

Page: [1035 - 1064] Pages: 30

DOI: 10.2174/1389200222666211126100023

Price: $65

Abstract

The goal of the biotransformation process is to develop structural changes and generate new chemical compounds, which can occur naturally in mammalian and microbial organisms, such as filamentous fungi, and represent a tool to achieve enhanced bioactive compounds. Cunninghamella spp. is among the fungal models most widely used in biotransformation processes at phase I and II reactions, mimicking the metabolism of drugs and xenobiotics in mammals and generating new molecules based on substances of natural and synthetic origin. Therefore, the goal of this review is to highlight the studies involving the biotransformation of Cunninghamella species between January 2015 and March 2021, in addition to updating existing studies to identify the similarities between the human metabolite and Cunninghamella patterns of active compounds, with related advantages and challenges, and providing new tools for further studies in this scope.

Keywords: Filamentous fungi, metabolism, chemical modifications, green chemical, cytochrome P450, xenobiotics.

Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy